Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Remimazolam	298
Overall Study	STARTED	Placebo	60
Overall Study	STARTED	Midazolam	103
Overall Study	Modified Intention to Treat (mITT)	Remimazolam	296
Overall Study	Modified Intention to Treat (mITT)	Placebo	60
Overall Study	Modified Intention to Treat (mITT)	Midazolam	102
Overall Study	Safety Population	Remimazolam	296
Overall Study	Safety Population	Placebo	60
Overall Study	Safety Population	Midazolam	102
Overall Study	COMPLETED	Remimazolam	296
Overall Study	COMPLETED	Placebo	59
Overall Study	COMPLETED	Midazolam	101
Overall Study	NOT COMPLETED	Remimazolam	2
Overall Study	NOT COMPLETED	Placebo	1
Overall Study	NOT COMPLETED	Midazolam	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02290873/flow